FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372553000: Substance with mast cell stabilizer mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1207396015 Mast cell stabiliser en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1208208011 Mast cell stabilizer en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3746925015 Substance with mast cell stabilizer mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
188881000077112 stabilisant mastocytaire fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

11 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mast cell stabiliser Is a antiallergique false Inferred relationship Some
Mast cell stabiliser Is a classe d'allergènes false Inferred relationship Some
Mast cell stabiliser Is a allergène médicamenteux false Inferred relationship Some
Mast cell stabiliser Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some
Mast cell stabiliser Is a Substance categorized by disposition true Inferred relationship Some
Mast cell stabiliser This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Mast cell stabilizer (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Amlexanox Is a True Mast cell stabiliser Inferred relationship Some
Ketotifen fumarate Is a True Mast cell stabiliser Inferred relationship Some
Pemirolast potassium Is a True Mast cell stabiliser Inferred relationship Some
Lodoxamide (substance) Is a True Mast cell stabiliser Inferred relationship Some
Product containing nedocromil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing olopatadine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing mast cell stabilizer (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Mast cell stabiliser Inferred relationship Some 1
Product containing cromoglicic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate [gastro-intestinal use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate [asthma] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate 20mg inhalation capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate 20mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate 5mg inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate 5mg inhaler+spacer The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate 5mg breath-actuated aerosol inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate compounds The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Ketotifen [asthma prophylaxis] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely ketotifen 1 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely ketotifen 1 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Ketotifen 1mg/5mL elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium [asthma] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium 2 mg/actuation pressurized suspension for inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium 2mg inhaler+spacer The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Ketotifen [antihistamine] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium 20 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate+isoprenaline sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing cromoglicate sodium and salbutamol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate 2% preservative-free eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromoglycate and related antiallergenic The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing sodium cromoglycate in oral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Inhaled sodium cromoglycate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing sodium cromoglycate in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing ketotifen (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 20mg/2 mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium 2% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 0.8mg/inh The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium 1.75mg/inh The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 20mg/amp solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 100mg/5mL gas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Olopatadine hydrochloride 0.1% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 5.2mg/spr solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 10mg/mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 800mcg/inh The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 40mg/spr solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 8.1g spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 40mg/mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 0.8mg/spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Ophthalmic cromolyn sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Ketotifen [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Ketotifen 250micrograms/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing cromolyn sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Sodium cromoglycate+xylometazoline hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing precisely ketotifen (as ketotifen fumarate) 250 microgram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Olopatadine (as olopatadine hydrochloride) 1 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromolyn sodium 100mg/5ml oral concentrate solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Nedocromil sodium 2% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Pemirolast (substance) Is a True Mast cell stabiliser Inferred relationship Some
Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing ketotifen in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Product containing ketotifen in ophthalmic dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Mast cell stabiliser Inferred relationship Some
Cromoglicic acid Is a True Mast cell stabiliser Inferred relationship Some
Nedocromil (substance) Is a True Mast cell stabiliser Inferred relationship Some
Nedocromil sodium Is a True Mast cell stabiliser Inferred relationship Some
Lodoxamide trometamol Is a True Mast cell stabiliser Inferred relationship Some
Sodium cromoglicate Is a True Mast cell stabiliser Inferred relationship Some
Adverse reaction to mast cell stabilizer (disorder) Causative agent (attribute) True Mast cell stabiliser Inferred relationship Some 1
Ketotifen (substance) Is a True Mast cell stabiliser Inferred relationship Some

This concept is not in any reference sets

Back to Start